Strategies for managing the side effects of treatments for multiple sclerosis.
about
Cutaneous adverse events associated with disease-modifying treatment in multiple sclerosis: a systematic reviewRisk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple SclerosisMechanism of action of oral fingolimod (FTY720) in multiple sclerosis.Classification of time series gene expression in clinical studies via integration of biological networkAKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple SclerosisEvaluation of the effects of a new drug candidate (GEMSP) in a chronic EAE modelManagement Strategies for Flu-Like Symptoms and Injection-Site Reactions Associated with Peginterferon Beta-1a: Obtaining Recommendations Using the Delphi Technique.Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis.Recognizing nonadherence in patients with multiple sclerosis and maintaining treatment adherence in the long term.The Combined Effect of Nursing Support and Adverse Event Mitigation on Adherence to Interferon Beta-1b Therapy in Early Multiple Sclerosis: The START Study.Clinical effects and tolerability of high-dose, high-frequency recombinant interferon beta-1a in patients with multiple sclerosis: maximizing therapy through long-term adherence.Managing treatment fatigue in patients with multiple sclerosis on long-term therapy: the role of multiple sclerosis nurses.A study to evaluate the effect of ultrasound treatment on nodules in multiple sclerosis patients.Improving compliance with interferon-beta therapy in patients with multiple sclerosis.A Multimodal, Nonpharmacologic Intervention Improves Mood and Cognitive Function in People with Multiple Sclerosis.Disease-modifying agents in the Sonya Slifka Longitudinal Multiple Sclerosis Study.Non-adherence to interferon-beta therapy in Swedish patients with multiple sclerosis.
P2860
Q22241795-8E1E4D77-F56F-4EE8-A8EA-23776B47B65FQ28087414-9A99FD86-A438-4908-9E26-421A5411F25CQ33810559-EDAD676E-E590-4045-A364-D4BAD61F92CCQ34629565-94DA2283-5575-4238-A2BD-188929A3BC9CQ35826151-B547019E-B7B0-46C1-B50D-F50BA67FF980Q36690274-B78844F0-547C-43DE-B99E-66B2EE2FFDF5Q37174681-DD0B6EC1-5363-452B-85E7-85462CCE9579Q37297572-488F10C7-5CDA-4E4D-99D3-B190FAB991DAQ37325484-6E31E569-45E2-4EA4-9B0B-F2BF83461EAFQ37442217-28E699D3-D31B-4439-AF1F-878B7A804ABDQ37706612-770B3F6C-9406-4436-9DAD-5B80D472301BQ38244521-8771F67D-1D8F-4FB3-AADE-DE35848F5766Q39173105-9BF7CB90-8FBF-4D3D-97C2-96E4E55AD2D1Q47695538-9DE229BC-A392-4205-A1FE-1730CD7FBF90Q47920404-F26EA864-2F9E-460F-943E-00088800EE21Q50127828-C9DE8ED6-0522-45EA-A59B-5BF46C0E2D18Q50783669-A1E59971-156C-4AA2-937B-AAB27D8529A2
P2860
Strategies for managing the side effects of treatments for multiple sclerosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Strategies for managing the side effects of treatments for multiple sclerosis.
@ast
Strategies for managing the side effects of treatments for multiple sclerosis.
@en
type
label
Strategies for managing the side effects of treatments for multiple sclerosis.
@ast
Strategies for managing the side effects of treatments for multiple sclerosis.
@en
prefLabel
Strategies for managing the side effects of treatments for multiple sclerosis.
@ast
Strategies for managing the side effects of treatments for multiple sclerosis.
@en
P2093
P1433
P1476
Strategies for managing the side effects of treatments for multiple sclerosis.
@en
P2093
Annette Langer-Gould
Harold H Moses
T Jock Murray
P304
P356
10.1212/WNL.63.11_SUPPL_5.S35
P407
P433
11 Suppl 5
P577
2004-12-01T00:00:00Z